Breaking News Instant updates and real-time market news.

ELGX

Endologix

$1.69

-0.06 (-3.43%)

16:02
10/02/18
10/02
16:02
10/02/18
16:02

Endologix reports preliminary Q3 revenue $34.3M-$34.7M , consensus $31.13M

  • 02

    Oct

  • 06

    Nov

  • 27

    Nov

ELGX Endologix
$1.69

-0.06 (-3.43%)

01/02/18
JPMS
01/02/18
DOWNGRADE
Target $5
JPMS
Underweight
Endologix downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Michael Weinstein downgraded Endologix to Underweight and cut his price target for the shares to $5 from $6. The outlook for the company continued to "deteriorate" over the course of 2017 as pipeline and regulatory challenges mounted, Weinstein tells investors in a research note. He sees an "uncertain path to profitability" and a "very long" road to recovery for Endologix.
03/20/18
PIPR
03/20/18
NO CHANGE
PIPR
Endologix ENCORE study a positive sign, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien was positive on Endologix's ENCORE study results for its Ovation product, and continues to believe "additional data reads and imminent approvals in the coming years should lift shares higher." O'Brien maintained an Overweight rating on shares, recommending investors with more risk tolerance or a longer time horizon accumulate shares at this point.
08/10/18
PIPR
08/10/18
DOWNGRADE
Target $4.75
PIPR
Neutral
Endologix downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brien downgraded Endologix to Neutral and lowered his price target for the shares to $4.75 from $7. The big news from the company's Q2 results is that management is meaningfully reducing revenue guidance for the year as it moves to revamp the business, O'Brien tells investors in a research note. Changes are a good idea "but the risks here are steep (lingering employee disruption, product safety concerns) compared to the rewards ," the analyst contends. He wants to move to the sidelines and see how the reorganization of the business takes shape.
08/23/18
BTIG
08/23/18
NO CHANGE
Target $4
BTIG
Buy
Endologix price target lowered to $4 from $7 at BTIG
BTIG analyst Sean Lavin lowered his price target on Endologix to $4 to reflect the company's recent "drastic" reduction in FY18 revenue guidance, cuts in salesforce, and delayed clinical timelines. Lavin adds that Endologix's Q2 earnings call was also "completely negative", saying the stock is the "Cleveland Browns of MedTech World", with high potential but propensity for things to go wrong. The analyst keeps his Buy rating on Endologix on valuation, but adds that "investors will need the patience of a Browns' fan to stay involved."

TODAY'S FREE FLY STORIES

CEMI

Chembio Diagnostics

$9.68

-0.05 (-0.51%)

16:41
10/22/18
10/22
16:41
10/22/18
16:41
Earnings
Chembio Diagnostics sees Q3 revenue $9.2M-$9.5M, two estimate consensus $8.05M »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CIEN

Ciena

$30.97

0.23 (0.75%)

16:41
10/22/18
10/22
16:41
10/22/18
16:41
Initiation
Ciena initiated  »

Ciena resumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSTM

HealthStream

$28.30

0.39 (1.40%)

16:40
10/22/18
10/22
16:40
10/22/18
16:40
Earnings
HealthStream sees FY18 revenue growth of 6%-8%, consensus $229.26M »

"Consistent with our…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HSTM

HealthStream

$28.30

0.39 (1.40%)

16:38
10/22/18
10/22
16:38
10/22/18
16:38
Hot Stocks
HealthStream CFO Gerard Hayden, Jr. resigns, Scott Roberts named interim CFO »

HealthStream's CFO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

AFMD

Affimed N.V.

$3.15

-0.06 (-1.87%)

16:38
10/22/18
10/22
16:38
10/22/18
16:38
Syndicate
Breaking Syndicate news story on Affimed N.V. »

Affimed N.V. files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$102.58

-0.48 (-0.47%)

16:37
10/22/18
10/22
16:37
10/22/18
16:37
Hot Stocks
ResMed says it won German patent infringement case against Fisher & Paykel »

ResMed announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

FN

Fabrinet

$44.71

-0.3 (-0.67%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Initiation
Fabrinet initiated  »

Fabrinet resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$186.64

0.47 (0.25%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Hot Stocks
Wex signs agreement to acquire Noventis »

WEX announced the signing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 26

    Nov

GOOG

Alphabet

$1,100.52

4.11 (0.37%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Hot Stocks
Google's YouTube investing $20M in education resources for 'EduTubers' »

YouTube is investing $20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

HSTM

HealthStream

$28.30

0.39 (1.40%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Earnings
HealthStream reports Q3 EPS 9c, consensus 8c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WASH

Washington Trust

$52.03

-1.25 (-2.35%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Earnings
Washington Trust reports Q3 EPS $1.01, consensus 98c »

"Washington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FNSR

Finisar

$17.61

-0.19 (-1.07%)

16:34
10/22/18
10/22
16:34
10/22/18
16:34
Initiation
Finisar initiated  »

Finisar resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFSC

Enterprise Financial

$45.76

-1.44 (-3.05%)

16:33
10/22/18
10/22
16:33
10/22/18
16:33
Earnings
Enterprise Financial reports Q3 core EPS 86c, consensus 89c »

Reports Q3 core revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HXL

Hexcel

$62.38

-0.7 (-1.11%)

16:33
10/22/18
10/22
16:33
10/22/18
16:33
Hot Stocks
Hexcel backs FY18 free cash flow greater than $230M »

Backs FY18 accrual basis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HXL

Hexcel

$62.38

-0.7 (-1.11%)

16:32
10/22/18
10/22
16:32
10/22/18
16:32
Earnings
Hexcel narrows FY18 adjusted EPS view to $2.99-$3.07 from 2.96-$3.10 »

FY18 consensus $3.03.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

KEYS

Keysight Technologies

$61.96

0.21 (0.34%)

16:32
10/22/18
10/22
16:32
10/22/18
16:32
Initiation
Keysight Technologies initiated  »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOS

BioScrip

$2.93

(0.00%)

16:31
10/22/18
10/22
16:31
10/22/18
16:31
Hot Stocks
BioScrip names John McMahon CAO »

BioScrip announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

LITE

Lumentum

16:31
10/22/18
10/22
16:31
10/22/18
16:31
Initiation
Lumentum initiated  »

Lumentum resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

INFN

Infinera

$6.06

-0.105 (-1.70%)

16:31
10/22/18
10/22
16:31
10/22/18
16:31
Initiation
Infinera initiated  »

Infinera resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSC

Harsco

$24.62

-0.14 (-0.57%)

16:31
10/22/18
10/22
16:31
10/22/18
16:31
Hot Stocks
Harsco names CEO Grasberger III as chairman of the board »

Harsco Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

HXL

Hexcel

$62.38

-0.7 (-1.11%)

16:30
10/22/18
10/22
16:30
10/22/18
16:30
Earnings
Hexcel reports Q3 adjusted EPS 80c, consensus 78c »

Reports Q3 revenue $540M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

16:30
10/22/18
10/22
16:30
10/22/18
16:30
Options
Preliminary option volume of 17.4M today »

Preliminary option volume…

ANGI

Angi Homeservices

$19.24

-0.1 (-0.52%)

16:29
10/22/18
10/22
16:29
10/22/18
16:29
Syndicate
Breaking Syndicate news story on Angi Homeservices »

Angi Homeservices files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

VIAV

Viavi

$11.93

-0.11 (-0.91%)

16:29
10/22/18
10/22
16:29
10/22/18
16:29
Initiation
Viavi initiated  »

Viavi resumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ANET

Arista Networks

$232.10

2.31 (1.01%)

16:28
10/22/18
10/22
16:28
10/22/18
16:28
Initiation
Arista Networks initiated  »

Arista Networks resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 01

    Nov

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.